Clinical Trial Update: Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combined nortriptyline and a transdermal nicotine patch for smoking cessation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Nortriptyline (nortriptyline)
• Transdermal nicotine patch (Nicotine)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Smoking | Phase 2 | Status: COMPLETED